0001567619-23-000700.txt : 20230106
0001567619-23-000700.hdr.sgml : 20230106
20230106213057
ACCESSION NUMBER: 0001567619-23-000700
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230106
FILED AS OF DATE: 20230106
DATE AS OF CHANGE: 20230106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital, LLC
CENTRAL INDEX KEY: 0001587114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40532
FILM NUMBER: 23516357
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Graphite Bio, Inc.
CENTRAL INDEX KEY: 0001815776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 844867570
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 484-0886
MAIL ADDRESS:
STREET 1: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Integral Medicines, Inc.
DATE OF NAME CHANGE: 20200622
3
1
doc1.xml
FORM 3
X0206
3
2023-01-06
0
0001815776
Graphite Bio, Inc.
GRPH
0001587114
EcoR1 Capital, LLC
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
Common Stock
8538446
I
See Notes 1 and 2
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
Qualified Fund directly holds 8,039,801 of the shares of Common Stock reported in this Form 3.
Oleg Nodelman, Manager of EcoR1 Capital, LLC
2023-01-06